ILF2 promotes anchorage independence through direct regulation of PTEN
1Pathology Department, Xingtai Medical College, Xingtai, Hebei 054000, P.R. China.
Abstract:
Anoikis is a specific form of programmed cell death induced by loss of contact between cells and extracellular matrices or other cells. Only tumor cells that are resistant to anoikis can survive in the state of detachment from the primary tissue during the early stages of metastasis. The ability to resist anoikis is crucial for cancer cell metastasis. ILF2 is a proto-oncogene previously studied in glioma, NSCLC, esophageal cancer and pancreatic ductal carcinoma. The results from the present study revealed that the transcription factor interleukin enhancer-binding factor 2 (ILF2) was highly expressed in non-small cell lung cancer (NSCLC) cell lines compared with in normal cell lines. ChIP and luciferase reporter gene assays demonstrated that ILF2 inhibited the expression level of the tumor suppressor gene phosphatase and tensin homolog (PTEN) by directly binding to its upstream regulatory region. Furthermore, the results from the detection of cell adhesion and apoptosis in cell suspension culture demonstrated that this mechanism enabled NSCLC cells to reduce adherence to the matrix and to survive in this abnormal state. These results suggested that ILF2 may promote the anchorage-independence of NSCLC cells through the suppression of PTEN.
Insights
Interleukin enhancer-binding factor 2 (ILF2) promotes non-small cell lung cancer (NSCLC) metastasis by inhibiting the tumor suppressor PTEN. This allows cancer cells to survive detachment, a key step in cancer spread.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Anoikis is programmed cell death triggered by loss of cell-matrix or cell-cell contact.
- Resistance to anoikis is essential for cancer cell metastasis.
- Interleukin enhancer-binding factor 2 (ILF2) is implicated as a proto-oncogene in various cancers.
Purpose of the Study:
- To investigate the role of ILF2 in non-small cell lung cancer (NSCLC).
- To elucidate the mechanism by which ILF2 influences cancer cell survival and metastasis.
Main Methods:
- Quantitative analysis of ILF2 expression in NSCLC cell lines versus normal cell lines.
- Chromatin immunoprecipitation (ChIP) assays to determine ILF2 binding to PTEN regulatory regions.
- Luciferase reporter gene assays to assess ILF2's effect on PTEN expression.
- Cell suspension culture to evaluate anoikis resistance and cell adhesion.
Main Results:
- ILF2 was significantly upregulated in NSCLC cell lines compared to normal cells.
- ILF2 directly binds to the upstream regulatory region of the phosphatase and tensin homolog (PTEN) gene.
- ILF2 suppresses PTEN expression, leading to reduced cell adhesion and increased survival in suspension.
- This mechanism promotes anchorage-independence in NSCLC cells.
Conclusions:
- ILF2 promotes anchorage-independence in NSCLC cells by inhibiting the tumor suppressor PTEN.
- ILF2-mediated suppression of PTEN is a critical mechanism enabling NSCLC cells to resist anoikis and survive detachment.
- ILF2 represents a potential therapeutic target for inhibiting NSCLC metastasis.
Related Concept Videos
The Eukaryotic Promoter Region
Introduction to Test of Independence
The test statistic for a test of independence is similar to that of a goodness-of-fit test:
Hypothesis Test for Test of Independence
H0: The two variables (factors)...
Master Transcription Regulators
Law of Independent Assortment
Positive Regulator Molecules


